Diet Drug Controversy As U.S. Approves Meds Rejected By Europe

An experienced physician doubts the validity of the FDA’s approval of Eisai’s Belviq and Vivus’ Qsymia after both anti-obesity drugs were banned in the European Union.
Medical News Today